Montelukast reduces eosinophilic inflammation by inhibiting both epithelial cell cytokine secretion (GM-CSF, IL-6, IL-8) and eosinophil survival
J. Mullol, F.B. Callejas, E. Méndez-Arancibia, M. Fuentes, I. Alobid, A. Martínez-Antón, A. Valero, C. Picado, J. Roca-Ferrer
Montelukast reduces eosinophilic inflammation by inhibiting both epithelial cell cytokine secretion (GM-CSF, IL-6, IL-8) and eosinophil survival
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |